[go: up one dir, main page]

ZA922006B - A composition comprising a peptide for nasal administration - Google Patents

A composition comprising a peptide for nasal administration

Info

Publication number
ZA922006B
ZA922006B ZA922006A ZA922006A ZA922006B ZA 922006 B ZA922006 B ZA 922006B ZA 922006 A ZA922006 A ZA 922006A ZA 922006 A ZA922006 A ZA 922006A ZA 922006 B ZA922006 B ZA 922006B
Authority
ZA
South Africa
Prior art keywords
peptide
composition
nasal administration
nasal
administration
Prior art date
Application number
ZA922006A
Other languages
English (en)
Inventor
Annie Rassing Hoelgaard
Rassing Hoelgaard Annie
Birgitte Smedemark Dath
Smedemark Dath Birgitte
Linda Mindeholm
Mindeholm Linda
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA922006B publication Critical patent/ZA922006B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA922006A 1991-03-20 1992-03-19 A composition comprising a peptide for nasal administration ZA922006B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91497A DK49791D0 (da) 1991-03-20 1991-03-20 Nasalt pulverpraeparat

Publications (1)

Publication Number Publication Date
ZA922006B true ZA922006B (en) 1992-11-25

Family

ID=8094234

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922006A ZA922006B (en) 1991-03-20 1992-03-19 A composition comprising a peptide for nasal administration

Country Status (5)

Country Link
AU (1) AU1468792A (da)
DK (1) DK49791D0 (da)
MX (1) MX9203615A (da)
WO (1) WO1992016196A1 (da)
ZA (1) ZA922006B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006873A6 (nl) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Toedieningsformulering voor nasale insuline toediening.
JP3098401B2 (ja) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 経鼻投与用製剤
JP2006500387A (ja) * 2002-08-15 2006-01-05 雲清 劉 固形ナノ医薬およびその調製方法
US20050031549A1 (en) * 2003-06-09 2005-02-10 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
JP5254618B2 (ja) * 2004-10-11 2013-08-07 ナサリーズ・ピーピーエム・リミテッド 経鼻投与用組成物
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
EP2046284A1 (en) * 2006-08-04 2009-04-15 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
PT3258919T (pt) * 2015-02-17 2020-03-26 Lilly Co Eli Formulação em pó nasal para tratamento da hipoglicemia
TWI771669B (zh) * 2019-04-26 2022-07-21 美商美國禮來大藥廠 製備穩定胜肽調配物之方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
IL78425A (en) * 1985-04-15 1991-05-12 Lilly Co Eli Intranasal formulation containing insulin
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
NL9001681A (nl) * 1990-07-24 1992-02-17 Rijksuniversiteit Transmucosale geneesmiddelpreparaten en transmucosale toediening.

Also Published As

Publication number Publication date
WO1992016196A1 (en) 1992-10-01
AU1468792A (en) 1992-10-21
DK49791D0 (da) 1991-03-20
MX9203615A (es) 1992-09-01

Similar Documents

Publication Publication Date Title
IL104068A0 (en) Pharmaceutical compositions for inhalation
GB9120024D0 (en) Nasal pharmaceutical composition
IL101289A0 (en) Inhaler for solid medicaments
ZA937697B (en) Pharmaceutical compositions containing a calcitonin
HU9401474D0 (en) New peptide derivatives
GB9108080D0 (en) Pharmaceutical composition
AP9200356A0 (en) Pharmaceutical composition
ZA922006B (en) A composition comprising a peptide for nasal administration
IL102372A0 (en) Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
GB2257908B (en) Calcitonin analogue for transmucosal administration
GB9111477D0 (en) Pharmaceutical composition
IL97365A0 (en) Pharmaceutical compositions comprising a lymphokine
GB2252497B (en) Pharmaceutical composition
ZA923243B (en) New peptide compound and a process for the preparation thereof
HU9200678D0 (en) Peptide analogues
GB9206151D0 (en) Nasal pharmaceutical composition
GB9018039D0 (en) A pharmaceutical composition
ZA916592B (en) A pharmaceutical composition
HU911556D0 (en) A new medicament
GB9121304D0 (en) A novel pharmaceutical formulation
GB9320906D0 (en) Medicament administration inhaler
IL100147A0 (en) Pharmaceutical delivery system
GB9119399D0 (en) Oral delivery system
IL97079A0 (en) Nasal drops
GB9101527D0 (en) Inhaler